ASIC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASIC's Piotroski F-Score of 4/9 indicates a borderline stable financial health, falling short of strong fundamentals. The absence of an Altman Z-Score raises concern about default risk, especially given the company's lack of disclosed debt and cash metrics. While the Graham Number ($21.31) and intrinsic value ($11.06) suggest undervaluation, the current price of $19.36 trades at a premium to intrinsic value, likely due to strong profitability and recent earnings surprises. The stock shows solid growth momentum in revenue (17.9% YoY) and consistent earnings beats (3/4 quarters), but earnings declined 9% YoY, creating a mixed signal. Analysts maintain a 'buy' recommendation with a $26.80 target, indicating optimism despite the valuation premium.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
ASIC vs JPM: Head-to-Head Comparison
This page compares Ategrity Specialty Insurance Company Holdings (ASIC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.